These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31828371)

  • 1. [Development of malaria vaccines-state of the art].
    Metzger WG; Sulyok Z; Theurer A; Köhler C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):45-55. PubMed ID: 31828371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.
    Walther M
    Expert Rev Vaccines; 2006 Feb; 5(1):81-93. PubMed ID: 16451110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The world's first malaria vaccine: Hope and challenge].
    Zhang YL; Pan WQ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Jan; 33(6):560-562. PubMed ID: 35128884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The March Toward Malaria Vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S319-33. PubMed ID: 26590432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria vaccine: the pros and cons.
    Saleh JA; Yusuph H; Zailani SB; Aji B
    Niger J Med; 2010; 19(1):8-13. PubMed ID: 20232750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development.
    Mandala WL; Harawa V; Dzinjalamala F; Tembo D
    Mol Biochem Parasitol; 2021 Nov; 246():111425. PubMed ID: 34666102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of malaria vaccines: SPf66--what next?
    Tanner M; Alonso PL
    Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].
    Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M
    Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.
    Bojang KA; Milligan PJ; Pinder M; Vigneron L; Alloueche A; Kester KE; Ballou WR; Conway DJ; Reece WH; Gothard P; Yamuah L; Delchambre M; Voss G; Greenwood BM; Hill A; McAdam KP; Tornieporth N; Cohen JD; Doherty T;
    Lancet; 2001 Dec; 358(9297):1927-34. PubMed ID: 11747915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.
    Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Aide P; Sigauque B; Milman J; Mandomando I; Bassat Q; Guinovart C; Espasa M; Corachan S; Lievens M; Navia MM; Dubois MC; Menendez C; Dubovsky F; Cohen J; Thompson R; Ballou WR
    Lancet; 2005 Dec; 366(9502):2012-8. PubMed ID: 16338450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Potential challenges for large-scale uses of RTS, S/AS01 vaccine in malaria-endemic areas].
    Feng GQ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Jan; 33(6):553-554. PubMed ID: 35128881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
    Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Milman J; Mandomando I; Spiessens B; Guinovart C; Espasa M; Bassat Q; Aide P; Ofori-Anyinam O; Navia MM; Corachan S; Ceuppens M; Dubois MC; Demoitié MA; Dubovsky F; Menéndez C; Tornieporth N; Ballou WR; Thompson R; Cohen J
    Lancet; 2004 Oct 16-22; 364(9443):1411-20. PubMed ID: 15488216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.
    Mahmoudi S; Keshavarz H
    Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for
    Takashima E; Otsuki H; Morita M; Ito D; Nagaoka H; Yuguchi T; Hassan I; Tsuboi T
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and challenges in malaria vaccine development.
    Wang R; Smith JD; Kappe SH
    Expert Rev Mol Med; 2009 Dec; 11():e39. PubMed ID: 20003658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
    Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
    Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RTS,S/AS01 vaccine (Mosquirix™): an overview.
    Laurens MB
    Hum Vaccin Immunother; 2020 Mar; 16(3):480-489. PubMed ID: 31545128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RTS,S/AS01, a vaccine targeting pre-erythrocytic stages of Plasmodium falciparum.
    von Seidlein L; Hanboonkunupakarn B; Jittmala P; Pukrittayakamee S
    Emerg Top Life Sci; 2017 Dec; 1(6):533-537. PubMed ID: 33525840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.